ARQT Jul 2024 5.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 11:27AM EDT
| Previous close | 3.0000 |
| Open | N/A |
| Bid | 3.2000 |
| Ask | 6.8000 |
| Strike | 5.00 |
| Expiry date | 2024-07-19 |
| Day's range | 3.0000 - 3.0000 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
ZacksFDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma
Following the label expansion, AbbVie's (ABBV) Epkinly is the first bispecific antibody approved to treat relapsed/refractory (R/R) follicular lymphoma and R/R diffuse large B-cell lymphoma.
ZacksAstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
Data from a late-stage study shows that treatment with AstraZeneca's (AZN) Imfinzi plus chemotherapy before and after bladder removal surgery improves survival in patients.
ZacksFDA Expands argenx's (ARGX) Vyvgart Label to Treat Rare Disorder
Per argenx (ARGX), the label expansion to Vyvgart Hytrulo makes it the first FDA-approved medication with a novel mechanism of action to treat chronic inflammatory demyelinating polyneuropathy.
© 2024 Yahoo. All rights reserved.